Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine 1527

1527 - TERT promoter mutation in a primary lesion of papillary thyroid carcinoma predicts absent or lower 131I uptake in a metastatic lesion (ID 1236)

Session Name
Endocrinology (Clinical Therapy) Posters
Speakers
Authors
Presentation Topic
Oncology: Clinical Therapy and Diagnosis -> Clinical Therapy -> Endocrinology/Neuroendocrine
Presentation Number
1527

Previous Eposter
1008 - The case for DOTA as a pharmacokinetic modulator for 18F-labeled peptides: DOTA-[18F]AMBF3-LLP2A for improved PET imaging of VLA-4 over-expression in murine melanoma (ID 60)

Next Eposters
1291 - Prediction of 99mTc-HMPAO-labeled leukocyte scintigraphy results in patients with knee arthroplasty by means of a new semiquantitave parameter in three-phase bone scan (ID 731)
1351 - Accelerated SPECT Image Reconstruction with a Convolutional Neural Network (ID 859)
188 - Performance of a Dual-Layer Scanner for Hybrid SPECT/CBCT (ID 103)
1258 - Is F18-FDG PET useful in Surveillance of Head and Neck Cancer (ID 610)
1297 - Semi-automatic quantitative assessment of site-specific bone health using spectral photon counting CT (ID 737)
1479 - Role of FDG PET scan in seizure focus localization in patients with unremarkable brain MRI (ID 1169)
26 - Diuresis-Renography with method F+10sp, a gravity-assisted approach for functional evaluation of uretero-ileal anastomosis. (ID 516)
3025 - Use of Doxorubicin for Radioiodine Targeted Therapy of Treatment Resistant Metastatic Breast Cancer, Hepatocellular Cancer, and Colon Cancer (ID 255)
1618 - Development and preclinical PET imaging of 68Ga-tin colloid for visualization and quantification of the phagocytic function of Kupffer cells (ID 1370)
3021 - Characterization of a novel â sheet-structured peptide for pretargeting immunotherapy of amyloidosis (ID 251)